NASDAQ: BKYI
Bio Key International Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their BKYI stock forecasts and price targets.

Forecast return on equity

Is BKYI forecast to generate an efficient return?

Company
-58.51%
Industry
37.13%
Market
331.11%
BKYI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BKYI forecast to generate an efficient return on assets?

Company
-34.97%
Industry
9.94%
BKYI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BKYI earnings per share forecast

What is BKYI's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.51
Avg 2 year Forecast
-$0.33

BKYI revenue forecast

What is BKYI's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$7.4M+17.89%
Avg 2 year Forecast
$9.2M+45.34%
BKYI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BKYI revenue growth forecast

How is BKYI forecast to perform vs Security & Protection Services companies and vs the US market?

Company
17.89%
Industry
3.54%
Market
1,453.22%
BKYI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BKYI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BKYI vs Security & Protection Service Stocks

TickerPricePrice TargetUp/downsideConsensus
BKYI$0.77N/AN/A
SUGP$5.60N/AN/A
VRME$0.74$1.50+102.70%Buy
UUU$4.00N/AN/A
IVDA$1.19N/AN/A

Bio Key International Stock Forecast FAQ

What is BKYI's earnings growth forecast for 2025-2026?

(NASDAQ: BKYI) Bio Key International's forecast annual earnings growth rate of N/A is not forecast to beat the US Security & Protection Services industry's average forecast earnings growth rate of 19.33%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,947.47%.

Bio Key International's earnings in 2025 is -$4,253,287.On average, 3 Wall Street analysts forecast BKYI's earnings for 2025 to be -$5,526,675, with the lowest BKYI earnings forecast at -$5,309,943, and the highest BKYI earnings forecast at -$5,689,224.

In 2026, BKYI is forecast to generate -$3,537,072 in earnings, with the lowest earnings forecast at -$3,398,363 and the highest earnings forecast at -$3,641,104.

If you're new to stock investing, here's how to buy Bio Key International stock.

What is BKYI's revenue growth forecast for 2025-2026?

(NASDAQ: BKYI) Bio Key International's forecast annual revenue growth rate of 17.89% is forecast to beat the US Security & Protection Services industry's average forecast revenue growth rate of 3.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,453.22%.

Bio Key International's revenue in 2025 is $6,316,050.On average, 3 Wall Street analysts forecast BKYI's revenue for 2025 to be $80,689,458, with the lowest BKYI revenue forecast at $77,525,165, and the highest BKYI revenue forecast at $83,062,677.

In 2026, BKYI is forecast to generate $99,480,153 in revenue, with the lowest revenue forecast at $95,578,971 and the highest revenue forecast at $102,406,040.

What is BKYI's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: BKYI) forecast ROA is -34.97%, which is lower than the forecast US Security & Protection Services industry average of 9.94%.

What is BKYI's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: BKYI) Bio Key International's current Earnings Per Share (EPS) is -$0.91. On average, analysts forecast that BKYI's EPS will be -$0.51 for 2025, with the lowest EPS forecast at -$0.49, and the highest EPS forecast at -$0.53. In 2026, BKYI's EPS is forecast to hit -$0.33 (min: -$0.31, max: -$0.34).

What is BKYI's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: BKYI) forecast ROE is -58.51%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.